Although the decreased levels of adiponectin in T2 diabetic subjects are associated with increased risk of cardiovascular disease [57], the levels of adiponectin are increased in T1 diabetic patients who suffer from micro vascular complications [79]. This evidence concerns the gene ADIPOQ and complication.